Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
![Foto de Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer](/img/grupo.png)
![Foto de Centro de Investigaciones Biológicas](/img/noimage_org.png)
Centro de Investigaciones Biológicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (17)
2024
-
Endothelial-to-Mesenchymal Transition in an Hereditary Hemorrhagic Telangiectasia-like Pediatric Case of Multiple Pulmonary Arteriovenous Malformations
International Journal of Molecular Sciences, Vol. 25, Núm. 11
-
Molecular and Cellular Characterization of Primary Endothelial Cells from a Familial Cavernomatosis Patient
International Journal of Molecular Sciences, Vol. 25, Núm. 7
2023
-
Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth
Acta Neurochirurgica, Vol. 165, Núm. 12, pp. 4241-4251
2022
-
A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2
Journal of Clinical Medicine, Vol. 11, Núm. 11
-
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Journal of Clinical Medicine, Vol. 11, Núm. 15
-
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
International Journal of Molecular Sciences, Vol. 23, Núm. 8
2020
-
CLN5 in heterozygosis may protect against the development of tumors in a VHL patient
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
Review of pharmacological strategies with repurposed drugs for hereditary hemorrhagic telangiectasia related bleeding
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-22
-
Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-30
2019
-
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: Phase III clinical trial
BMJ Open Ophthalmology, Vol. 4, Núm. 1
-
The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease
Scientific Reports, Vol. 9, Núm. 1
-
c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial–Mesenchymal Transition and Regulates Cell Phenotypic Switch
Stem Cells, Vol. 37, Núm. 8, pp. 1108-1118
2013
-
Glucagon regulation of oxidative phosphorylation requires an increase in matrix adenine nucleotide content through Ca2+ activation of the mitochondrial ATP-Mg/Pi carrier SCaMC-3
Journal of Biological Chemistry, Vol. 288, Núm. 11, pp. 7791-7802
2012
-
C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1823, Núm. 8, pp. 1366-1377
2009
-
p53 regulates the self-renewal and differentiation of neural precursors
Neuroscience, Vol. 158, Núm. 4, pp. 1378-1389
2007
-
Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation
Apoptosis, Vol. 12, Núm. 9, pp. 1733-1742
-
p38α MAPK can positively or negatively regulate Rac-1 activity depending on the presence of serum
FEBS Letters, Vol. 581, Núm. 20, pp. 3819-3825